54 results
424B5
VRDN
Viridian Therapeutics Inc
19 Jan 24
Prospectus supplement for primary offering
4:32pm
significant medical benefit for patients. We are engineering medicines to address unmet medical needs for patients and further advance drug innovation
424B5
VRDN
Viridian Therapeutics Inc
17 Jan 24
Prospectus supplement for primary offering
4:04pm
medical benefit for patients. We are engineering medicines to address unmet medical needs for patients and further advance drug innovation.
Recent
S-3ASR
VRDN
Viridian Therapeutics Inc
30 Nov 23
Automatic shelf registration
4:05pm
significant medical benefit for patients. We are engineering medicines to address unmet medical needs for patients and further advance drug innovation … held in the aggregate by RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., and RTW Biotech Opportunities Ltd (collectively, the “RTW Funds
8-K
EX-10.1
uvzku3jy
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
EX-10.2
w8jnkki3z1642 tu24
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
S-3ASR
4j291cq
24 Jul 23
Automatic shelf registration
4:06pm
8-K
EX-99.1
i41da 9ioq
10 Mar 22
Viridian Therapeutics Reports Fourth Quarter and Full Year 2021
4:16pm